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ABSTRACT: Highly porous chitosan microspheres (CSM) were prepared through emulsion-21 
based thermally induced phase separation (TIPS) without using toxic crosslinkers and chemical 22 
porogenic agents other than ice. The CSM had an average diameter of ~150 μm with 23 
interconnected pores varying from 20~50 µm in size. Due to their excellent biocompatibility and 24 
unique porous structure, high-performance hepatocyte culture in three-dimensional (3D) space 25 
was achieved using the CSM as microcarriers, as cell growth also took place within the internal 26 
pores of the CSM, besides their external surface, and multidirectional cell–cell interactions were 27 
observed. Enhanced cellular activity and functions were obtained with the CSM microcarriers as 28 
compared with 2D cell culture. It is believed that these CSM microcarriers provide a promising 29 
platform for 3D cell culture in vitro. 30 




















 CSM were prepared by a mild procedure, free of toxic crosslinking agents and porogens. 50 
 The CSM have excellent biocompatibility and a unique porous structure. 51 
 Convincing evidence for 3D cell culture was obtained using the CSM as microcarriers. 52 








1. INTRODUCTION  60 
Traditional cell plate culture has been questioned because of potential changes in 61 
morphology and gene expression, often resulting in distortions in cell behavior and biological 62 
functions of cultured cells as compared with cells in natural organisms and tissues (Asghar et al., 63 
2015). To better maintain cell morphology, behavior and functions, the concept of three-64 
dimensional (3D) cell culture was proposed, that is cell growth in a 3D environment with 65 
sufficient and multidirectional cell–cell interactions mimicking the in vivo architecture of natural 66 
organs and tissues (Achilli, Meyer, & Morgan, 2012; Pampaloni, Reynaud, & Stelzer, 2007). 67 
Natural polymer-based scaffolds have received broad attention for 3D cell culture due to their 68 
good biocompatibility and designed structure (Higuchi et al., 2014; Kehr, 2016; Mazza et al., 69 
2015; Motealleh, Hermes, Jose & Kehr, 2018; Motealleh & Kehr, 2017; Song et al., 2017). For 70 
example, the group of Kehr developed alginate-based 3D hydrogel scaffolds containing periodic 71 
mesoporous organosilica or zeolite nanoparticles functionalized with the chiral biopolymers 72 
poly(L-lysine) and poly(D-lysine). Chirality-dependent cell adhesion and cell migration were 73 
investigated in these hydrogel scaffolds (Kehr, 2016; Motealleh et al., 2017; Motealleh et al., 74 
2018).  75 
The microcarrier culture technique, first introduced by van Wezel (1967), relies upon 76 
microspheres derived from various materials, with either a porous or a non-porous structure, as 77 
supports for anchoring cell lines. The main advantages of the microcarrier technology include a 78 
high surface area to mass ratio, the use of stirred microcarrier suspension culture, and easy scale-79 
up making it possible to culture a wide range of animal cells in high yield (Chen, Reuveny, & 80 
Oh, 2013). A wide range of commercial and experimental microcarriers have emerged over the 81 
past few decades (Duan et al., 2015; Fang et al., 2014; Healthcare & Biosciences, 2005; Yu, 82 
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Kornmuller, Brown, Hoare, & Flynn, 2017). However, it should be noted that most of the 83 
existing microcarriers only enable cell attachment and growth on their outermost surface, or else 84 
on their external pore surface, with either no or only unidirectional cell–cell interactions. This is 85 
in essence very similar to monolayer cell culture in plates, and thus may not be considered 3D 86 
cell culture in the strict sense. Indeed, real 3D cell culture with microcarriers should enable cell 87 
growth within the microcarriers in addition to their surface, with sufficient and multidirectional 88 
cell–cell interactions, to mimic more closely the in vivo environment experienced by cells in 89 
natural organs and tissues (Achilli et al., 2012). This is considered crucial for the cells to present 90 
normal behavior and function. Chung et al. (2008) fabricated amine-functionalized microcarriers 91 
with a well-interconnected pore structure from poly(lactic-co-glycolic acid) (PLGA), through 92 
gas-promoted foaming in a water-in-oil-in-water double emulsion, for cell cultivation and 93 
injectable delivery. Unfortunately, the seeded cells barely infiltrated the inner pores of these 94 
supports but rather attached onto their outer surface for the most part. The authors hypothesized 95 
that the highly porous skeletal structure of the microcarriers likely did not provide sufficient 96 
anchoring surface area for cell attachment within the interior void spaces. Many other 97 
microcarriers were reported that only achieved cell growth on their outer surface (Duan et al., 98 
2015; Yu et al., 2017; Zhang et al., 2018).  More recently, Yan et al. (2018) reported porous 99 
microcarriers fabricated from strontium-substituted hydroxyapatite-graft-poly(γ-benzyl L-100 
glutamate) nanocomposites. The adhesion and infiltration of rabbit adipose-derived stem cells 101 
(ADSCs) within the internal cavities of these microcarriers were confirmed by confocal 102 
microscopy. It was shown that labeled ADSCs could be detected at 1/8, 2/8, 3/8 and 4/8 diameter 103 
depths of the microcarriers, which implied that cell attachment and growth were allowed in the 104 
innermost regions of these microcarriers. 105 
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The biopolymer chitosan, obtained by the deacetylation of chitin, has been widely applied in 106 
the biomedical field because of its non-toxicity and good biodegradability (Anitha et al., 2014; 107 
Pellá et al., 2018). Different chitosan-based porous macroscopic scaffolds were developed for 3D 108 
cell culture (Tripathi & Melo, 2015; Westin, Trinca, Zuliani, Coimbra & Moraes, 2017). As an 109 
example, Tripathi et al. (2015) synthesized sponge-like composite agarose–chitosan scaffolds in 110 
various forms including monolith and disc shapes. Primary hepatocyte growth and cell–cell 111 
interactions within the interconnected pore network of these scaffolds were observed. Chitosan-112 
based microcarriers were also reported for cell culture (Custódio, Cerqueira, Marques, Reis & 113 
Mano, 2015; Tedesco et al., 2018; Wu et al., 2011; Zhang et al., 2018). For example, Zhang et al. 114 
(2018) developed chitosan-based microcarriers reinforced with graphene oxide through an acid-115 
dissolution/alkali-precipitation approach. These hybrid microspheres were able to support stem 116 
cell expansion, growth and proliferation. Custódio et al. (2015) also developed chitosan 117 
microcarriers, bioconjugated on their surface with monoclonal antibodies favoring cell capture 118 
and subsequent cell expansion. Although multiple chitosan-based microcarriers have been 119 
investigated over the past decade, there is only one report, by Fang et al. (2014), for which 3D 120 
cell culture was supported in the true sense, enabling cell migration to the inside of the carrier 121 
and multidirectional cellular interactions. This may be because porous chitosan microspheres are 122 
usually prepared by crosslinking emulsions, i.e. chitosan emulsion droplets are first formed, and 123 
then stabilized with a crosslinking reagent such as glutaraldehyde. Unfortunately, the pores of 124 
chitosan microspheres obtained by that method are not large enough to accommodate cells (Wu 125 
et al., 2011). Fang et al. (2014) first prepared porous chitosan microspheres with large pores 126 
(47.5 ± 5.4 μm) by a phase separation technique. Microcarriers, named PEC, were then 127 
fabricated by coating the chitosan microspheres with poly(L-glutamic acid) via electrostatic 128 
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interaction and evaluated for cartilage regeneration. The authors confirmed that the poly(L-129 
glutamic acid)-coated PEC microcarriers enabled the proliferation potential of chondrocytes, 130 
with cell infiltration and survival in the inner regions of the microcarriers. However they also 131 
stated that the poly(L-glutamic acid) modification played a vital role in 3D cell culture, as it 132 
enhanced the hydrophilicity of the microcarriers. We previously reported a simple and reliable 133 
emulsion-based thermally induced phase separation (TIPS) procedure to fabricate chitosan 134 
microspheres with large pores (J. Li et al., 2017). By adapting this preparation method for the 135 
current investigation, chitosan microspheres (CSM) with superior biocompatibility and a highly 136 
porous structure were obtained and fully characterized. In particular, the suitability of these as-137 
prepared chitosan microspheres as microcarriers for 3D hepatocyte culture was confirmed, 138 
without requiring surface modification. 139 
 140 
2. Materials and Methods 141 
2.1.  Materials and cell line.  142 
Chitosan (degree of deacetylation > 95%) was obtained from Sigma-Aldrich. Its 143 
viscosity-average molecular weight, determined with an Ubbelohde viscometer at 25C and the 144 
Mark-Houwink-Sakurada equation [η] = KMα, where K = 1.8×10-6 and α = 0.93 (Costa, 145 
Teixeira, Delpech, Souza, & Costa, 2015), was Mv = 1.02×106. The surfactants Span 80 (S80) 146 
and Tween 60 (T60), acetic acid, petroleum ether and sodium hydroxide (NaOH) were purchased 147 
from Shanghai Sinopharm Chemical Reagent Co. Ltd. All the reagents were analytical grade and 148 
were used without further purification.  149 
A human fetal hepatocyte line, L-02, obtained from Tongji Medical School, Huazhong 150 
University of Science and Technology (Wuhan, China) was cultured in RPMI-1640 medium 151 
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with 10% fetal bovine serum and 1% antibiotics (100 mg/mL streptomycin and 100 U/mL 152 
penicillin), by incubation at 37C in a humidified atmosphere containing 5% CO2.  153 
2.2. Preparation of porous chitosan microspheres (CSM).  154 
To fabricate porous CSM appropriate as 3D culture supports for the L-02 cells, a 155 
combination of micro-emulsification and low temperature thermally induced phase separation 156 
(L-TIPS) techniques was selected and adapted from the procedure described in our previous 157 
work (J. Li et al., 2017). Specifically, a 1% (w/v) aqueous chitosan solution was prepared by 158 
dissolving chitosan powder into 1% (w/v) aqueous acetic acid solution (ca. 0.167 M), to serve as 159 
the dispersed phase. The continuous phase was petroleum ether containing S80 and T60 160 
emulsifiers in a mass ratio (S80/T60) of 4.8/0.2, and a total mass content of 5% (w/v). The 161 
chitosan solution (10 mL) was added drop-wise into 50 mL of the continuous phase at 40C 162 
under magnetic stirring at 1000 rpm to obtain a w/o emulsion. After stirring for 3 h, the emulsion 163 
was quenched and stored at -20C for 3.5 h. A phase inversion liquid, in the form of 100 mL 1% 164 
(w/v) NaOH solution in ethanol and water (14:1, v/v), was then poured into the quenched 165 
emulsion under mild stirring. The chitosan microspheres that formed were collected by 166 
centrifugation and were successively washed with water and ethanol until the supernatant 167 
became neutral, before drying under vacuum at 30C. The as-prepared CS microspheres are 168 
identified as CSM (Scheme 1). 169 
 170 
Scheme 1. Fabrication procedure for the porous chitosan microspheres (CSM). 171 
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2.3. Characterization of the CSM.  172 
The morphology of the CSM was observed on a scanning electron microscope (SEM) 173 
(Quanta 200, FEI) at an accelerating voltage of 20.0 kV after sputter-coating with gold. To 174 
characterize the distribution of pores within the particles, the cross-sectional morphology of the 175 
CSM was visualized as follows. The CSM were first stained with 1% (w/v) Rhodamine B 176 
solution in ethanol. After vacuum drying at 30C for 10 h, they were embedded in paraffin and 177 
cut into 5 μm thick slices on a microtome (Leica RM2235). The cross-section structure was then 178 
observed on an Olympus BX51 optical microscope. The specific surface area was characterized 179 
by nitrogen adsorption-desorption isotherm analysis at 77 K (Micromeritics ASAP 2020 180 
apparatus). Other physical properties that were characterized include the porosity, pore size 181 
distribution, density, water absorption capacity and the elastic modulus. The protocols for these 182 
studies are provided in the Supplementary Information. 183 
2.4. Biocompatibility assay.  184 
The contact cytotoxicity and non-contact cytotoxicity of the CSM were evaluated with L-185 
02 cells. Blood compatibility assays were also performed for the CSM through determination of 186 
the hemolysis rate. The specific protocols used for these studies are provided in the 187 
Supplementary Information.  188 
2.5. Cell attachment on/in the CSM. 189 
 A CSM suspension in water (4 mg/mL), sterilized by autoclaving, was added to a L-02 190 
cell suspension in culture medium (1×105 cells/mL) in a volume ratio of 1:1. After gentle mixing 191 
on a shaker for 1 h, the cell/CSM suspension was transferred to a 24-well plate at 1 mL/well. 192 
After incubation for 10 h the cells were washed with PBS three times, followed by progressive 193 
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dehydration in 30%, 50%, 70%, 90%, 95% and 100% ethanol for 10 min each. After freeze-194 
drying, the samples were carefully removed with forceps and placed on conductive adhesive tape 195 
on a platform for SEM (SU8010, Hitachi) observation after sputter-coating with gold. The 196 
fractured surface of the CSM/cell complex was also obtained and imaged by SEM after the same 197 
pretreatment. To determine the cell distribution within the CSM, the cells were stained with 198 
Calcein-AM (2 μM) and observed by laser scanning confocal microscopy (Olympus FV1000, 199 
Japan) at different depths of the CSM after incubation for 48 h. 200 
2.6. Cell activity evaluation.  201 
The viability of cells cultured on the CSM microcarriers was assessed using a live/dead 202 
assay kit (Dojindo, Japan). The L-02 cells were cultured with 2 mg/mL of CSM in a 35 mm 203 
confocal dish (In Vitro Scientific, USA) for 12, 24, 48 or 72 h, respectively. Working solutions 204 
of Calcein-AM (2 μM) and PI (4 μM) were prepared from stock solutions. After washing the 205 
cells with PBS solution three times, an equimolar mixture of dyes was added at 500 μL/well. 206 
After incubation at 37C for 30 min, the samples were observed by laser scanning confocal 207 
microscopy (Nikon A1, Japan) using an excitation wavelength of 490 nm and the green emission 208 
at 515 nm to observe the live cells, while an excitation wavelength of 535 nm and the red 209 
emission at 615 nm were used to observe the dead cells. To further evaluate cell activity, the cell 210 
shape was determined by laser scanning confocal microscopy (Olympus FV1000, Japan) after 211 
incubation with the CSM for 48 h. The cell nuclei and cell membranes were stained with 212 
Hoechst 33258 (Beyotime, China) (10 μg/mL) and DiI (Beyotime, China) (10 μM), respectively. 213 
An excitation wavelength of 405 nm and the blue emission were used to observe the cell nuclei, 214 
while an excitation wavelength of 559 nm and the red emission served to observe the cell 215 
membranes. 216 
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2.7. Albumin and urea secretion.  217 
The concentration of albumin (ALB) and urea in the culture medium was determined by 218 
the competitive enzyme linked immunosorbent assay (ELISA). The cell culture supernatants 219 
were collected in a sterile tube after centrifugation for 20 min at 2000 rpm. Aliquots of standards 220 
and diluted supernatants (100 µL each) were added to the antibody-coated wells. After 221 
incubation for 1 h, the wells were washed three times and incubated with ALB antibody labeled 222 
with horseradish peroxidase (HRP) for 1 h. After washing three times, 3,3’,5,5’-223 
tetramethylbenzidine (TMB) substrate solution was added before incubation in the dark for 30 224 
min. The OD values were measured spectrophotometrically at 450 nm. The concentration of 225 
ALB in the samples was determined by comparing the OD values for the samples to a standard 226 
curve. 227 
2.8. Gene expression.  228 
Total RNA extraction from the L-02 cells was achieved with a RNApure Tissue & Cell 229 
Kit (CWBIO, China), after the cells were cultured with 2 mg/mL of CSM for 48 h in a 6-well 230 
plate at a seeding density of 30×104 cells/well. The total RNA was adjusted to 1.0 μg/sample 231 
before it was transcribed into cDNA with a Frist Strand cDNA Synthesis Kit (TOYOBO, Japan) 232 
according to the instructions. Fluorescence-based quantitative PCR was conducted using a 7500 233 
Fast Real-time PCR system (Applied Biosystems, USA) and SYBR Select Master Mix (Applied 234 
Biosystems, USA) according to the manufacturers’ guidelines. The specific quantitative primers 235 
were synthesized by BGI (Shenzhen, China) with sequences as follows: 236 
GAPDH: 5’- ACAACTTTGGTATCGTGGAAGG-3’(sense) and 5’-237 
GCCATCACGCCACAGTTTC-3’(antisense);  238 
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CYP2E1: 5’-GGGAAACAGGGCAATGAGAG-3’(sense) and 5’-239 
GGAAGGTGGGGTCGAAAGG-3’(antisense);  240 
GST: 5’-AACCTCAACTGAACAGCATCC-3’(sense) and 5’-241 
GGTTGGTCTTGGTCCTCCTAT-3’(antisense);  242 
MRP: 5’-AAGGAGGTACTAGGTGGGCTT-3’(sense) and 5’-243 
CCAGTAGGACCCTTCGAGC-3’(antisense);  244 
ASS1: 5’-TCCGTGGTTCTGGCCTACA-3’(sense) and 5’-GGCTTCCTCGAAGTCTTCCTT-245 
3’(antisense). 246 
2.9. Proteomics analysis.  247 
The cells were lysed and total protein extraction was achieved by the same treatment 248 
described above. The protein concentration was determined by the Bradford protein assay. Then 249 
the samples were thermally denatured, reduced and alkylated prior to trypsin (Progmega) 250 
digestion for 15 h. The digested proteins were labelled with an iTRAQ reagent kit (8 plex, 251 
Applied Biosystems) according to the protocol supplied. The fractionated peptide mixtures were 252 
analyzed on a Q-Exactive mass spectrometer equipped with an EASY-nLC 1000 System 253 
(Thermo Fisher Scientific). The parameters for the spray voltage, capillary temperature and 254 
declustering potential of the source ionization were set at 2.1 kV, 250C and 100 V, 255 
respectively. 256 
2.10. Western blot analysis.  257 
For western blot analysis, equal amounts of proteins (20 µg/sample) were separated on 258 
SDS-PAGE and transferred onto a PVDF membrane. After blocking overnight, the membrane 259 
was successively incubated with primary antibody and HRP-conjugate secondary antibody at 260 
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37C for 1 h with shaking. The bands were visualized using Pierce ECL Western Blotting 261 
(Thermo Scientific, USA). 262 
2.11. Statistical analysis. 263 
  Quantitative data are expressed as the arithmetic mean value ± standard deviation (SD). 264 
All the quantitative results were obtained from at least triplicate samples. A t-test was used to 265 
detect differences between groups, with p < 0.05 considered statistically significant and p < 266 
0.001 considered highly statistically significant. 267 
3. RESULTS AND DISCUSSION 268 
3.1. Morphological and physical properties of the CSM.  269 
The structure of the CSM obtained by the method described is visible in Figure 1. The 270 
microspheres have a spherical topology, a diameter of ca. 150 µm and a large number of 271 
irregular pores varying from 20 to 50 µm in diameter (Figure 1A). The pores are interconnected, 272 
as can be seen more clearly from the enlarged image section provided in Figure 1B. This was 273 
further confirmed by optical microscopy of the microtomed material providing cross-section 274 
views of the CSM as exemplified in Figure 1C, likewise revealing the presence of multiple 275 
interconnected pores in the 20~50 µm range throughout the whole particles. It was demonstrated 276 
in our previous study (J. Li et al., 2017) that such a structure is due to the mechanism of TIPS. 277 
Upon quenching the emulsion droplets to -20C, solid–liquid phase separation occurs within 278 
them, and the water/acetic acid solvent mixture undergoes slow crystallization allowing the ice 279 
crystals to gradually grow larger, leaving behind irregular pores on and within the CSM after the 280 
ice crystals are removed. It was further verified that the pore size in the microspheres could be 281 
controlled by adjusting the quenching temperature (Fang et al., 2014; J. Li et al., 2017): The pore 282 
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size decreases as the quenching temperature is lowered, because a relatively fast crystallization 283 
process produces smaller crystals. TIPS is a well-established method for the preparation of 284 
porous materials. Crystalline polymers such as polylactide (PLA) and PLGA are often employed 285 
to prepare porous materials by the TIPS technique (Ahmadi, Mordan, Forbes, & Day, 2011; 286 
Nina, Raheleh, & M., 2015; Zhang & Ma, 2015), but chitosan-based porous materials have been 287 
also obtained by the same approach (J. Li et al., 2017; Tripathi et al., 2015). 288 
The porosity of the CSM, determined by a liquid displacement method, was as high as 289 
98.00.5 %, which leads to a very low density of 0.0400.006 g/cm3 for the dry CSM. The 290 
distribution of pore sizes was also estimated by mercury injection. The results in Figure 1D 291 
demonstrate that most pores are within a range of 10~60 µm, with an average diameter of 27.8 292 
µm, which is in good agreement with the SEM observations. The specific surface area was 293 
measured to be 30.00.7 m2/g, much higher than for the commercial Cytopore microcarriers 294 
(reported to be 1.0~3.0 m2/g) (Healthcare & Biosciences, 2005; Ikonomou, Drugmand, Bastin, 295 
Schneider, & Agathos, 2002; Xiao et al., 1999). It is believed that microcarriers with a high 296 
specific surface area can provide a large number of anchoring sites for the cells, which is crucial 297 
to achieve high density cell culture (Yanagi, Miyoshi, Fukuda, & Ohshima, 1992). It was indeed 298 
suggested that large pores and a high pore interconnectivity within engineered scaffolds promote 299 
oxygen/nutrients diffusion, facilitating the in-growth and distribution of cells throughout the 300 
constructs (Chiu et al., 2011; Huang et al., 2012). The CSM possess a high water absorption 301 
capacity of as much as 2300%, enabling the microcarriers to form stable suspensions in the cell 302 
culture medium.  303 
Elasticity is one of the most important characteristics of cell microcarriers. On the one hand, it 304 
can influence cell behaviors such as differentiation and messenger expression; on the other hand, 305 
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sufficient elasticity is required for the microcarriers to withstand shear forces in stirred 306 
bioreactors (Cha, Liechty, Khademhosseini, & Peppas, 2012; K. Li et al., 2004; Radaei, 307 
Mashayekhan, & Vakilian, 2017). The elastic modulus of the CSM measured by atomic force 308 
microscopy (AFM) in the wet state was 153 kPa (see Supplementary Information), which is 309 
slightly higher than for Cytopore microcarriers. Elastic modulus analysis for soft microspheres 310 
was also conducted by other researchers using AFM. For instance, Radaei et al. (2017) measured 311 
elastic modulus values of 34~133 kPa for gelatin/chitosan blend microspheres, depending on 312 
their composition.  313 
 314 
Figure 1. Structural and physical properties of the CSM: (A) SEM image; (B) Enlarged section 315 
of SEM image; (C) Optical microscopy image for a cross-section view; (D) Pore size 316 
distribution. 317 
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When the CSM are applied as microcarriers for cell culture, the highly porous structures with 318 
interconnected pores, mainly within a size range of 20~50 µm, are expected to provide a large 319 
surface area for cell attachment and a good 3D environment for cell in-growth. Their elasticity 320 
should allow them to remain intact under shear, in addition to supporting the cells. Moreover, the 321 
CSM preparation is free of toxic crosslinking agents (such as glutaraldehyde) and porogens 322 
(other than ice), making the CSM microcarriers totally toxin-free in composition, which is 323 
favorable for growth in cell cultures. Consequently, these as-prepared microcarriers were 324 
expected to have a good performance in 3D cell culture.  325 
 326 
3.2. Cytotoxicity and blood compatibility.  327 
The in vitro cytotoxicity of the CSM to L-02 cells was studied using the CCK-8 assay, 328 
and the results obtained are provided in Figure 2. The viability of L-02 cells incubated with CSM 329 
extract (non-contact; Figure 2A) and CSM suspensions (contact; Figure 2B) displayed no 330 
significant change at all the concentrations tested, with cell viability over 100% in all cases. 331 
Moreover, it is noted that the viability of L-02 cells incubated with the CSM was higher than for 332 
cells incubated with the CSM extract, which suggests that the CSM provided good anchorage 333 
facilitating cell adhesion, growth and proliferation. The blood compatibility of the CSM was 334 
evaluated by the hemolysis test (Figure 2C). It can be seen that the hemolysis rate with CSM at 335 
different concentrations (0.5, 1 and 2 mg/mL) was ca. 0.14%, 0.70% and 1.07%, respectively. 336 
According to standard ASTM-F/756-08 (2000), a hemolysis rate < 2% is defined as non-337 
hemolytic (Seyfert, Biehl, & Schenk, 2002). The CSM are therefore considered non-hemolytic 338 
over the concentration range investigated. The trend of increasing hemolysis rate with CSM 339 
concentration is ascribed to the positive surface charges on the CSM, which could interact 340 
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electrostatically with the red blood cells. These superior cell and blood compatibility results 341 
indicate that the CSM are highly biocompatible and suitable for biomedical applications 342 
involving cell and blood contact. 343 
 344 
Figure 2. Biocompatibility evaluation: (A) Non-contact and (B) contact cytotoxicity of the CSM 345 
by CCK-8 assay with L-02 cells; (C) Hemolysis test for the CSM at different concentrations. 346 
 347 
3.3. Hepatocyte culture with the CSM microcarriers and evaluation.  348 
SEM images for L-02 cells incubated with the CSM microcarriers for 10 h are shown in 349 
Figures 3A~C. It is clear that the L-02 cells (indicated by the red arrows) were attached and grew 350 
within the internal pores of the microcarriers, in addition to the outermost surface and the 351 
external pore surface (Figure 3A). Multidirectional cell–cell interactions were established and 352 
extracellular matrix seems to be visible surrounding the cells (Figures 3B, C), suggesting that the 353 
cells adapted rapidly to the new environment in the CSM microcarriers and remained in good 354 
condition. The fractured surface of a CSM seeded with L-02 cells and incubated for 10 h was 355 
also imaged by SEM; it is presented in the Supplementary Information (Figure S2). It is clearly 356 
seen that cells are distributed across the whole fractured surface of the CSM, in addition to the 357 
edge. This indicates that cells were able to grow within the internal pores of the CSM, in addition 358 
to their external surface. To further confirm cell in-growth within the microcarriers, cell cultures 359 
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with the microcarriers were investigated by confocal microscopy after incubation for 48 h. As 360 
shown in Figures 3D~F, Calcein-AM labeled cells (green) were detected at different depths 361 
within the microcarrier from 25 μm to 75 μm. This indicates without any doubt that the cells 362 
were able to infiltrate and grow within the inner pores of the CSM.  363 
 364 
Figure 3. Hepatocyte culture with the CSM microcarriers: A~C. SEM images confirming the 365 
attachment and growth of L-02 cells on/in the CSM microcarriers after incubation for 10 h. The 366 
red arrows indicate L-02 cells; D~F. Confocal microscopic images showing cell infiltration and 367 
growth at depths of 25, 50, and 75 µm within the microcarriers after incubation for 48 h. 368 
To evaluate cell activity, the Live/Dead assay was used to monitor the growth and proliferation 369 
of L-02 cells on/in the CSM microcarriers. Confocal laser scanning microscopy images for L-02 370 
cells with specific live-dead staining after 12, 24, 48 or 72 h of incubation with the microcarriers 371 
are provided in Figure 4. The live cells were stained with Calcein-AM (green), while the dead 372 
cells were stained with Propidium Iodide (PI) (red). It can be seen that the cells incubated with 373 
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the microcarriers were highly active, with dead cells hardly observed over the time interval 374 
studied. The cell number in the microcarriers increased with time from 12 to 72 h, as reflected in 375 
the increased green fluorescence. These results clearly indicate that the CSM microcarriers can 376 
support cell survival and proliferation. To further examine cell activity, the cell shape was 377 
determined after incubation with the CSM for 48 h, by staining the cell nuclei and membranes 378 
with Hoechst 33258 and DiI, respectively. As shown in Figure 5, the L-02 cells exhibited an 379 
epithelial-like morphology, which implies the cells had good growth and proliferation status (Hu 380 
et al., 2013). 381 
The success of the 3D cell culture achieved with the CSM microcarriers is attributed to their 382 
unique porous structure, with interconnected pores of 20~50 µm, in addition to the good 383 
biocompatibility of chitosan, both of which promote good cell adhesion, growth and 384 
multidirectional cell–cell interactions. It was indeed suggested that a porous structure plays a 385 
vital role in cell culture, because it promotes not only the adhesion, migration and distribution of 386 
cells, but also for the exchange of nutrients and metabolic waste (Choi, Xie, & Xia, 2009). To 387 
achieve high-performance cell culture with porous microcarriers or scaffolds, the pore size 388 
should fall within an appropriate range (Murphy, Haugh, & O'Brien, 2010; O’Brien, Harley, 389 
Yannas, & Gibson, 2005; Yannas, Lee, Orgill, Skrabut, & Murphy, 1989). If the pore size is too 390 
small, cell migration is limited, resulting in the formation of a cellular capsule around the 391 
microcarriers. Conversely, if the pore size is too large, there is a decrease in surface area limiting 392 
cell adhesion (Murphy et al., 2010). The optimal pore size can vary from tens to hundreds of 393 
microns for different cell lines, however (O’Brien et al., 2005; Yannas et al., 1989). The pores 394 
should also be interconnected to allow sufficient multidirectional cell–cell interactions within the 395 




Figure 4. Confocal laser scanning microscopy images for L-02 cells after 12, 24, 48 and 72 h of 399 




Figure 5. Cellular morphology observation by confocal microscopy after incubation with the 403 
CSM microcarriers for 48 h: A. Cell nuclei stained with Hoechst 33258; B. Cell membranes 404 
stained with DiI; C. Merged image of A and B; D. Bright field image. Scale bar: 50 µm. 405 
 406 
3.4 Liver function investigation.  407 
The mRNA expression of liver function-related genes including CYP2E1 408 
(cytochromeP450, family2, subfamilyE, polypeptide1), GST (glutathione-S-transferase), MRP 409 
(multidrug resistance-related proteins) and ASS1 (argininosuccinate synthase 1) was investigated 410 
in L-02 cells cultured with the CSM microcarriers for 48 h. As can be seen in Figure 6A, the 411 
mRNA expression levels for the above genes in the CSM-cultured L-02 cells were not 412 
significantly different from L-02 cells not exposed to the microcarriers. This indicates that the 413 
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CSM microcarriers had no negative effects on the expression of liver function-related genes in 414 
the L-02 cells.  415 
The expression of proteins related to liver functions in L-02 cells cultured on the CSM 416 
microcarriers was studied by proteomics analysis. The relative quantitative expression of the 417 
liver function-related proteins OGT1 (UDP glucuronosyl transferase), GST, HGS (hepatocyte 418 
growth factor-regulated tyrosine kinase substrate), DHE3 (glutamate dehydrogenase 1, 419 
mitochondrial), GPX 1,4 (glutathione peroxidase 1,4) and GSH0 (glutamate-cysteine ligase 420 
regulatory subunit 0) is depicted in Figure 6B. The results of western blot analysis for MRP and 421 
ASS1 are shown in the upper part of Figure 6B. Similarly to gene expression, protein expression 422 
related to liver functions in L-02 cells cultured on the CSM microcarriers was almost the same as 423 
for L-02 cells not exposed to the microcarriers. This indicates that the CSM microcarriers had no 424 
negative effects on the expression of liver function-related proteins in the L-02 cells.   425 
To further examine the hepatocellular functions, the albumin secretion and urea synthesis 426 
ability were investigated in L-02 cells cultured on the CSM microcarriers. The results, shown in 427 
Figure 6C,D, demonstrate that as compared with cells cultured in plates, cells seeded on the 428 
CSM produced significantly more albumin each day over the 4-day period investigated, while 429 
urea synthesis was also significantly enhanced over the first two days. These results suggest that 430 
L-02 cells cultured on the CSM microcarriers had a higher activity than cells cultured in plates, 431 
which is probably due to the formation of cell-cell interactions in 3D space in the former case. 432 
With regards to the expression of the different hepatocyte functions, it is known that the 433 
establishment of adequate intracellular communication between cells is important (Nakazawa, 434 
Izumi, & Mori, 2009); because the L-02 cells cultured on the CSM microcarriers presumably had 435 
better intercellular communication than in the cell monolayers, they may be able to express 436 
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higher hepatocyte functions. It is noted that the secretion of albumin and the synthesis of urea 437 
decreased over time for cells cultured on both the microcarriers and in plates (Figure 6C,D). 438 
Similar results for hepatocyte functions in vitro were reported in the literature (Chua et al., 2005; 439 
Seo et al., 2005). For example, Chua et al. (2005) reported hepatocyte culture on galactosylated 440 
poly(ε-caprolactone-co-ethyl ethylene phosphate) nanofiber and film scaffolds. They also found 441 
that the albumin and urea synthesis functions of the hepatocytes decreased over a 5-day period. 442 
However, other studies demonstrated that the hepatocyte functions were maintained or even 443 
increased over time (Isoda et al., 2004). This shows the complexity of hepatocyte function 444 
maintenance, in that the expression of hepatocyte functions could be influenced by different 445 
biochemical and topological cues, among others.  446 
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 447 
Figure 6. Liver function evaluation for L-02 cells cultured with the CSM microcarriers: (A) 448 
mRNA expression of liver function-related genes; (B) Liver function-related protein expression; 449 
(C) Albumin secretion; (D) Urea synthesis. 450 
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4. CONCLUSIONS 451 
Microcarriers based on porous chitosan microspheres (CSM) appropriate for 3D cell 452 
culture were developed, by adapting a simple emulsion-based thermally induced phase 453 
separation (TIPS) process to produce interconnected pores with a size appropriate to 454 
accommodate the cells. The mild preparation conditions used for the CSM, free of toxic reagents, 455 
ensured superior biocompatibility of the carriers. 3D cell culture was achieved using these 456 
microcarriers with hepatocytes, as cell growth was allowed within the internal pores, in addition 457 
to the outermost surface and the external pore surface, and multidirectional cell–cell interactions 458 
were observed. These CSM microcarriers are favorable to maintain the activity and functions of 459 
the cells in comparison with 2D cell culture in plates. On the basis of the results obtained, it is 460 
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Porosity and density 
The porosity of the CSM was determined via a liquid displacement method with ethanol as the 
displacement liquid, as reported in previous studies (Guan, Fujimoto, Sacks, & Wagner, 2005; Li 
et al., 2017). Briefly, a certain amount of CSM (MS) was added to a pycnometer containing 
absolute ethanol (M1). Then the bottle was subjected to low vacuum until the air in the scaffold 
was completely removed and replaced with ethanol. The bottle was then completely filled with 
ethanol and was weighed as M2. Then the CSM saturated with ethanol were collected by carefully 
draining the ethanol, the remaining ethanol on the CSM surface was removed with filter paper. 
The pycnometer containing wet CSM was weighed as M3. The volume of the CSM was calculated 
as VS = (M1 − M2 + M3 − M) / ρ (ethanol). The density (ρ) and porosity (P) were calculated using 
Equations (S1) and (S2): 
ρ = MS ρ(ethanol) / ( M1 +M3−M−M2)    (S1) 
P = VP/VS = [(M3−M−MS) / (M1−M2 +M3−M)]  100%    (S2) 
 
Pore size distribution 
The pore size distribution was estimated with a mercury injection apparatus (AutoPore IV 9500, 
Micromeritics Instrument Corporation). The equipment operated at pressures of 10 kPa to 300 
MPa, to probe pores with diameters ranging from 150 μm to 0.005 μm. The CSM samples were 




Water absorption capacity 
The water absorption capacity of the CSM was investigated as described previously [S1]. A 
certain amount of dry CSM (Md) was immersed into phosphate-buffered saline (PBS, pH 7.4) 
solution. The glass beaker containing the mixture was evacuated for 3 min, to allow filling of the 
pores in the CSM by the solution, and allowed to stand for 24 h. Subsequently, the PBS solution 
was discarded and excess liquid was removed with filter paper. The mass of the wet CSM (Mw) 
was measured. Triplicate measurements were made for each sample. The water absorption ratio 
(A) was calculated using Equation (S3):  
A = [(Mw- Md)/ Md]  100%    (S3) 
 
Elastic modulus 
The dry CSM were put into PBS solution and stirred at 400 rpm for 30 min. The elastic modulus 
(E) of the wet CSM was determined by analysis of the force-displacement curve on an atomic 
force microscopy (AFM) apparatus. The plot of force versus distance between the probe and the 
CSM surface was recorded as shown below (Figure S1). The set point was selected as 14 nN for a 
quadratic pyramid tip and the cantilever was lowered at a velocity of 1 μm/s. The constant spring 
of the cantilever (Kc) was 0.68 N/m. The local elastic modulus of the sample was calculated using 
the equations below (Kuznetsova, Starodubtseva, Yegorenkov, Chizhik, & Zhdanov, 2007; 




E              (S4) 
𝐹 Kc Ks ∆V,  in which Ks=∆Z1/∆V1     (S5) 
a                 (S6) 
In these equations, E is elastic modulus of the CSM; F is the force applied; 𝑎 is the Hertzian 
contact radius; Kc is the constant spring of cantilever (in this study, it was 0.68N/m.); Ks is the 
displacement sensitivity, which is the displacement of the scanner when the operating point 
changes by one volt. R is the radius of the CSM tested. Since the values of ∆V, ∆V1, ∆Z1 are known 
for the force curve (Figure S1), the elastic modulus (E) of the CSM can be calculated as 153 kPa. 
 





Cytotoxicity assay. For the non-contact cytotoxicity assays, a CSM extract was prepared 
according to ISO 10993-5. Briefly, sterilized CSM were immersed in cell culture medium at 
different concentrations of 0.5, 1.0 and 2.0 mg/mL at 37℃ for 72 h. Solid components were then 
removed by centrifugation at 10000 rpm for 5 min. The collected supernatant was used as CSM 
extract after filtration through a 0.22 μm filter membrane. The L-02 cells were seeded at 1×104 
cells/well in a 96-well plate and incubated at 37 ℃ in a 5% CO2 atmosphere overnight. The 
medium was then replaced with the CSM extract, using the cell culture medium as control. After 
incubation for 12, 24, 48 or 72 h, the cells were treated with 10 µL/well of CCK-8 (Dojindo, Japan) 
solution with shaking for 5 min and incubated for another 30 min. Absorbance values were 
measured in triplicate at 450 nm using a microplate reader (Multiskan GO, Thermo Fisher, USA). 
For contact cytotoxicity, the cells were seeded with the CSM at concentrations of 0.5, 1.0 and 2.0 
mg/mL, and the above procedures for the assessment of non-contact cytotoxicity were followed. 
Cell viability was calculated using Equation (S7), where ODS, ODB and ODN are the OD values 
for the sample, the blank control and the negative control, respectively. 




           (S7) 
 
Hemolysis rate test. To evaluate the blood compatibility of the CSM, the hemolysis rate was 
determined by the method described below. Fresh blood was collected from a healthy rabbit and 
mixed with heparin immediately to prevent clotting, before dilution with normal saline at a volume 
ratio of 1:1.25. The CSM samples at different concentrations (i.e. 0.5, 1.0 and 2.0 mg/mL) were 
S 6 /S 7 
 
pre-swelled in normal saline overnight. Distilled water and normal saline were used as positive 
and negative controls, respectively. All the samples (1.5 mL) were stored at 37°C in the presence 
of 50 µL of diluted blood for 30 min. The samples were then centrifuged at 1000 rpm for 5 min 
and the supernatant was subjected to absorbance measurements at 545 nm on a microplate reader 
(Multiskan GO, Thermo Scientific). The hemolysis rate was calculated using Equation (S8), where 
ODS, ODN, and ODP are the absorbance values for the sample, the negative control and the positive 
control, respectively. 




Figure S2  SEM image for a fractured surface of the CSM seeded with L-02 cells (indicated with 
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